Janet Hammond

Janet Hammond is a seasoned professional in the pharmaceutical and medical fields, currently serving as the Chief Development Officer at Atea Pharmaceuticals, Inc since August 2020. Prior to this role, Janet held the position of Vice President for Infectious Diseases and General Medicine at AbbVie from November 2016. Janet's extensive experience includes serving as Senior Vice President at Roche from March 2011, Chief Medical Officer and Senior Vice President of Medical Affairs at Valeant Pharmaceuticals from January 2007 to March 2011, and a board member at the American Heart Association from 2004 to 2007. Additionally, Janet worked as Group Director at Bristol-Myers Squibb from 2002 to 2007 and contributed as Clinical Program Head and Head of Clinical Discovery for Virology at GlaxoWellcome, GSK from 1997 to 2002. Janet received a Master of Science in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health between 1994 and 1997.